Back in August, it was reported that a simple pill taken at the onset of symptoms for COVID-19 reduced the risk of hospitalization and death by 50%. Now 1.7 million doses of that drug, an antiviral agent called Molnupiravir produced by Merck, have been secured for use in the U.S. and represents the first orally-ingested […]

The post Promising Results From Antiviral Pill May Change the Game for COVID-19 Effects, Finds Clinical Trial appeared first on Good News Network.

Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.